Cholinesterase inhibitor

DRUG2 trials

Sponsors

Sunnybrook Health Sciences Centre, VA Office of Research and Development

Conditions

Alzheimer's DiseaseDementia

Phase 2

Cholinesterase Inhibitor Discontinuation

CompletedNCT02248636

VA Office of Research and DevelopmentDementia

Start: 2015-01-22End: 2019-10-01Updated: 2020-10-23

Phase 3

Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease

CompletedNCT02035982

Sunnybrook Health Sciences CentreAlzheimer's Disease, Dementia

Start: 2010-07-31End: 2015-09-30Updated: 2017-04-28